Corteva, Inc. (NYSE:CTVA) Shares Purchased by Dearborn Partners LLC

Dearborn Partners LLC lifted its position in shares of Corteva, Inc. (NYSE:CTVA) by 5,353.8% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 547,230 shares of the company’s stock after acquiring an additional 537,196 shares during the period. Dearborn Partners LLC owned 0.08% of Corteva worth $31,170,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also recently bought and sold shares of CTVA. Davis R M Inc. increased its position in shares of Corteva by 11.4% in the fourth quarter. Davis R M Inc. now owns 5,389 shares of the company’s stock worth $307,000 after acquiring an additional 550 shares in the last quarter. Independent Advisor Alliance raised its position in shares of Corteva by 31.1% in the fourth quarter. Independent Advisor Alliance now owns 10,307 shares of the company’s stock valued at $587,000 after purchasing an additional 2,445 shares during the period. Daiwa Securities Group Inc. lifted its position in Corteva by 2.8% during the 4th quarter. Daiwa Securities Group Inc. now owns 110,829 shares of the company’s stock worth $6,313,000 after acquiring an additional 3,019 shares during the last quarter. Dorsey & Whitney Trust CO LLC lifted its position in shares of Corteva by 20.4% during the 4th quarter. Dorsey & Whitney Trust CO LLC now owns 46,292 shares of the company’s stock worth $2,637,000 after purchasing an additional 7,835 shares during the last quarter. Finally, Larson Financial Group LLC boosted its position in shares of Corteva by 155.3% in the fourth quarter. Larson Financial Group LLC now owns 17,762 shares of the company’s stock valued at $1,012,000 after acquiring an additional 10,805 shares during the period. Institutional investors own 81.54% of the company’s stock.

Corteva Stock Down 0.5 %

Corteva stock opened at $60.23 on Tuesday. The company has a quick ratio of 0.93, a current ratio of 1.45 and a debt-to-equity ratio of 0.08. The firm has a 50 day moving average price of $61.73 and a 200-day moving average price of $59.61. Corteva, Inc. has a twelve month low of $50.01 and a twelve month high of $66.24. The company has a market capitalization of $41.29 billion, a P/E ratio of 46.69, a P/E/G ratio of 1.68 and a beta of 0.79.

Corteva (NYSE:CTVA) last announced its quarterly earnings results on Wednesday, February 5th. The company reported $0.32 earnings per share for the quarter, missing the consensus estimate of $0.34 by ($0.02). Corteva had a net margin of 5.36% and a return on equity of 7.19%. As a group, equities analysts predict that Corteva, Inc. will post 2.96 EPS for the current year.

Corteva announced that its board has approved a stock repurchase program on Tuesday, November 19th that allows the company to repurchase $3.00 billion in shares. This repurchase authorization allows the company to purchase up to 7.5% of its stock through open market purchases. Stock repurchase programs are often a sign that the company’s board believes its shares are undervalued.

Corteva Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 17th. Stockholders of record on Monday, March 3rd will be issued a $0.17 dividend. The ex-dividend date is Monday, March 3rd. This represents a $0.68 annualized dividend and a dividend yield of 1.13%. Corteva’s dividend payout ratio is currently 52.71%.

Insider Buying and Selling at Corteva

In other Corteva news, insider Brian Titus sold 26,560 shares of the stock in a transaction on Thursday, February 20th. The stock was sold at an average price of $63.74, for a total value of $1,692,934.40. Following the completion of the transaction, the insider now owns 11,347 shares in the company, valued at approximately $723,257.78. This represents a 70.07 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 0.14% of the company’s stock.

Analyst Ratings Changes

Several analysts have recently weighed in on CTVA shares. Citigroup lifted their price objective on Corteva from $69.00 to $74.00 and gave the stock a “buy” rating in a report on Wednesday, January 29th. KeyCorp raised their price target on Corteva from $68.00 to $70.00 and gave the company an “overweight” rating in a report on Friday, February 7th. UBS Group reduced their target price on shares of Corteva from $74.00 to $73.00 and set a “buy” rating on the stock in a research report on Friday, January 10th. Wells Fargo & Company lifted their price objective on Corteva from $67.00 to $73.00 and gave the stock an “overweight” rating in a research report on Tuesday, January 28th. Finally, Oppenheimer increased their price target on Corteva from $70.00 to $72.00 and gave the company an “outperform” rating in a research note on Friday, February 7th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and twelve have assigned a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $67.79.

Corteva Company Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.